My work aims to elucidate how m6A, the most prevalent mRNA modification, regulates the response to hypoxia in cancer cells. We are focusing on mRNA export and decay, translation and splicing. We aim to understand the fine tuning between the response to hypoxia and m6A in cancer in order to design better therapies. Other interests and expertise involve stress response, protein aggregation, protein quality control, prions and ageing
University of Thessaly
Larissa, Greece
School of Medicine, Laboratory of Biochemistry
The Francis Crick Institute
London, City of London, UK